Built for confidence. Designed for discovery.
A Translational Platform for Obesity and Metabolic Disease Research
Obesity is a complex, multisystem disease, making well-characterized preclinical models critical for evaluating new therapeutic approaches. Inotiv's diet-induced obesity (DIO) mouse model provides a translational platform for investigating metabolic dysfunction and generating clinically relevant insights to support drug discovery.
Confidence Built Through Characterization and Validation
Inotiv's DIO model is benchmarked against established commercial models. And through its continued use in our own research, you benefit from ongoing monitoring, characterization, and revalidation, providing added confidence in consistent performance in your own studies.
Watch this 2-minute video to explore Inotiv's DIO platform and two ways to advance your research: source a validated DIO model for your in-house studies or partner with Inotiv for integrated discovery and safety studies.
Advance Your Obesity Research
Complete the form to connect with our scientists to discuss your research goals and how Inotiv's DIO model and integrated capabilities can support your program.
